These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8889372)

  • 1. End-stage renal disease: why aren't improvements in hypertension treatment reducing the risk?
    Jaimes E; Galceran JM; Raij L
    Curr Opin Cardiol; 1996 Sep; 11(5):471-6. PubMed ID: 8889372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal disease and black Americans: selected issues.
    Livingston IL
    Soc Sci Med; 1993 Sep; 37(5):613-21. PubMed ID: 8211275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. End-stage renal disease and race: an overview and perspective.
    Ferguson R
    J Natl Med Assoc; 1991 Sep; 83(9):794-8. PubMed ID: 1942113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality of blacks and whites with end-stage renal disease attributed to hypertension.
    Am J Kidney Dis; 1992 Nov; 20(5 Suppl 2):27-31. PubMed ID: 1442772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension as a risk factor for renal disease. Review of clinical and epidemiological evidence.
    Whelton PK; Klag MJ
    Hypertension; 1989 May; 13(5 Suppl):I19-27. PubMed ID: 2490824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study.
    Tanner RM; Calhoun DA; Bell EK; Bowling CB; Gutiérrez OM; Irvin MR; Lackland DT; Oparil S; McClellan W; Warnock DG; Muntner P
    Am J Kidney Dis; 2014 May; 63(5):781-8. PubMed ID: 24388119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension as a causative diagnosis of patients entering end-stage renal disease programs in the United States from 1980 to 1986.
    Blythe WB; Maddux FW
    Am J Kidney Dis; 1991 Jul; 18(1):33-7. PubMed ID: 2063853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update: women, hypertension and therapeutic efficacy.
    Jones CA; Nagpal S
    Can J Cardiol; 2001 Dec; 17(12):1283-9. PubMed ID: 11773939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiologic and pharmacotherapy considerations in the management of the black hypertensive patient.
    Cook CA
    Am Heart J; 1988 Jul; 116(1 Pt 2):288-95. PubMed ID: 2899388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in treatment of hypertension has not reduced incidence of end-stage renal disease.
    Seedat YK
    J Hum Hypertens; 1999 Nov; 13(11):747-51. PubMed ID: 10578218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A familial risk of chronic renal failure among blacks on dialysis?
    Ferguson R; Grim CE; Opgenorth TJ
    J Clin Epidemiol; 1988; 41(12):1189-96. PubMed ID: 3210065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Muntner P; Davis BR; Cushman WC; Bangalore S; Calhoun DA; Pressel SL; Black HR; Kostis JB; Probstfield JL; Whelton PK; Rahman M;
    Hypertension; 2014 Nov; 64(5):1012-21. PubMed ID: 25259745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial factors in the incidence and causation of end-stage renal disease (ESRD).
    Easterling RE
    Trans Am Soc Artif Intern Organs; 1977; 23():28-33. PubMed ID: 910346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension and kidney disease: a deadly connection.
    Barri YM
    Curr Hypertens Rep; 2008 Feb; 10(1):39-45. PubMed ID: 18367025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of blood pressure reduction on end stage renal disease.
    Jamerson K
    Am J Hypertens; 1996 Aug; 9(8):60s-64s. PubMed ID: 8862239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The enigma of hypertensive ESRD: observations on incidence and trends in 18 European, Canadian, and Asian-Pacific populations, 1998 to 2002.
    Stewart JH; McCredie MR; Williams SM; ; Fenton SS; Trpeski L; ; McDonald SP; ; Jager KJ; van Dijk PC; ; Finne P; ; Schon S; ; Leivestad T; ; Løkkegaard H; ; Billiouw JM; ; Kramar R; ; Magaz A; ; Vela E; ; Garcia-Blasco MJ; ; Ioannidis GA; ; Lim YN
    Am J Kidney Dis; 2006 Aug; 48(2):183-91. PubMed ID: 16860183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure indexes and end-stage renal disease risk in adults with chronic kidney disease.
    Bell EK; Gao L; Judd S; Glasser SP; McClellan W; Gutiérrez OM; Safford M; Lackland DT; Warnock DG; Muntner P
    Am J Hypertens; 2012 Jul; 25(7):789-96. PubMed ID: 22573012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension and endstage renal disease.
    Brown TE; Carter BL
    Ann Pharmacother; 1994 Mar; 28(3):359-66. PubMed ID: 8193427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical correlates of hypertensive end-stage renal disease.
    Bleyer AJ; Chen R; D'Agostino RB; Appel RG
    Am J Kidney Dis; 1998 Jan; 31(1):28-34. PubMed ID: 9428448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.